Jeffrey Peppercorn
Overview
Explore the profile of Jeffrey Peppercorn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
147
Citations
3067
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peppercorn J, Hasler J, Hu B, Tagai E, Zahner G, Lam A, et al.
Cancer
. 2025 Jan;
131(2):e35721.
PMID: 39813089
Background: Little is known about the role that charitable copay assistance (CPA) plays in addressing access to care and financial distress. The study sought to evaluate financial distress and experience...
2.
Peppercorn J, Gelin M, Masteralexis T, Zafar S, Nipp R
JCO Oncol Pract
. 2025 Jan;
21(1):5-11.
PMID: 39793546
Financial toxicity (FT) is now a well-recognized issue affecting many patients with cancer and their families. The field is rapidly moving from a focus on describing this problem to efforts...
3.
Spring L, Scarpetti L, Medford A, Niemierko A, Comander A, Mulvey T, et al.
NPJ Breast Cancer
. 2025 Jan;
11(1):2.
PMID: 39774684
Optimal timing and dosing of adjuvant cyclin-dependent kinase (CDK) 4/6 inhibitor in early breast cancer is controversial. This prospective phase II clinical trial investigated tolerability and safety of two ribociclib...
4.
5.
Hall D, Yeh G, OCleirigh C, Wagner L, Peppercorn J, Denninger J, et al.
Psychooncology
. 2024 Nov;
33(11):e70026.
PMID: 39549022
Introduction: Fear of cancer recurrence (FCR) is prevalent and distressing among survivors of cancer. Evidence-based mind-body and cognitive-behavioral skills lack integration and testing in scalable formats. Objective: This pilot randomized...
6.
DeCarli K, Bradbury A, Lopez A, Camacho P, Chatwal M, Friese C, et al.
JCO Oncol Pract
. 2024 Nov;
20(11):1508-1514.
PMID: 39531847
No abstract available.
7.
Millstein R, Lee H, Lapioli A, Winters L, Sullivan C, Bateman S, et al.
Am J Lifestyle Med
. 2024 Nov;
18(6):791-801.
PMID: 39507915
Background: Cancer survivorship guidelines emphasize Lifestyle Medicine (LM) pillars, including physical activity, healthy eating, restorative sleep, stress management, and avoiding risky substance use. We describe the development and patient population...
8.
9.
Willis K, Walsh E, Dunderdale L, Post K, Horick N, Antoni M, et al.
JCO Oncol Pract
. 2024 Aug;
20(12):1645-1654.
PMID: 39137385
Purpose: Adjuvant endocrine therapy (AET) is a life-saving medication for patients with hormone-sensitive breast cancer, yet many struggle with adherence, warranting behavioral intervention. In our recent trial, participation in a...
10.
Tesch M, Zheng Y, Rosenberg S, Poorvu P, Ruddy K, Tamimi R, et al.
NPJ Breast Cancer
. 2024 Aug;
10(1):67.
PMID: 39090124
Ovarian function suppression (OFS) benefits young women with hormone receptor (HR)-positive breast cancer but they are at risk for ovarian function breakthrough. We assessed endocrine effects of gonadotropin-releasing hormone agonist...